News | Artificial Intelligence | October 26, 2022

Industry life sciences veteran to advance growth strategy and execution

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai 

 


October 26, 2022 —  Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief marketing officer (CMO). Choe will report to CEO Chris Mansi, overseeing global marketing strategy, brand and communications, product marketing and demand generation. 

“Jieun’s deep experience and proven track record in driving growth with expert execution will be invaluable as we continue to expand our footprint worldwide,” said CEO Chris Mansi, M.D. “The addition of her customer-centric approach and strategic, growth mindset to our c-suite will help propel Viz.ai into new frontiers.” 

Choe was most recently chief strategy and marketing officer at Certara, a global leader in biosimulation, where she headed the global marketing team and drove the strategic planning process. Choe was also instrumental in helping lead the company to a successful IPO in December 2020. Earlier in her career, she worked in product management and strategy at Guidant and Boston Scientific, leading cross-functional teams and driving product strategy and launches. 

“I am thrilled to join Viz.ai as it embarks on its next stage of growth,” said Choe. “The company’s purpose-driven, diverse culture is impressive, empowering the Viz team to innovate outstanding solutions to improve patient outcomes and increase access to life-saving care. I look forward to working with the team to accelerate the momentum and fuel growth.” 

Choe received her Bachelors of Arts in Public Policy and Economics from Stanford University and a Masters of Business Administration from Stanford University’s Graduate School of Business

For more information: www.viz.ai 

Find more RSNA22 coverage here


Related Content

News | Artificial Intelligence

June 15, 2026 — HOPPR recently announced that HOPPR AI Foundry is now available in AWS Marketplace. The availability ...

Time June 19, 2026
arrow
News | Information Technology

June 9, 2026 — Mosaic Clinical Technologies, a wholly owned subsidiary of Radiology Partners, has launched Mosaic ...

Time June 15, 2026
arrow
News | Imaging Software Development

June 10, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, has launched Reporting Pro, an AI-powered ...

Time June 12, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
Subscribe Now